Quanterix (NASDAQ:QTRX) Announces Quarterly Earnings Results

Quanterix (NASDAQ:QTRX) posted its earnings results on Monday. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.03), Zacks reports. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Stock Up 3.1 %

QTRX stock traded up $0.22 during mid-day trading on Monday, reaching $7.28. 564,067 shares of the stock traded hands, compared to its average volume of 492,294. Quanterix has a 52 week low of $6.80 and a 52 week high of $27.37. The business has a 50-day moving average of $8.59 and a two-hundred day moving average of $11.01. The firm has a market capitalization of $280.45 million, a PE ratio of -6.87 and a beta of 1.33.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.